Abivax
French biotechnology company
Abivax is a French biotechnology company focused on developing therapies for inflammatory diseases, viral infections, and cancer. The company is headquartered in Paris, France, and is known for its innovative approach to drug development, particularly in the field of immunology.
History
Abivax was founded in 2013 with the aim of leveraging the immune system to treat a variety of diseases. Since its inception, the company has focused on developing small molecules and biologics that can modulate the immune response.
Research and Development
Abivax's research and development efforts are primarily centered around its lead product candidates, which target inflammatory diseases and viral infections. The company's pipeline includes several promising compounds in various stages of clinical development.
ABX464
One of Abivax's most advanced product candidates is ABX464, a small molecule with anti-inflammatory properties. ABX464 is being investigated for the treatment of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. The compound works by modulating the expression of microRNA, which plays a crucial role in the inflammatory process.
ABX196
Another key product in Abivax's pipeline is ABX196, an immune enhancer being developed for the treatment of hepatocellular carcinoma, a type of liver cancer. ABX196 is designed to activate natural killer T cells, which are part of the body's immune response against cancer cells.
Technology
Abivax utilizes a proprietary technology platform to identify and develop new therapeutic candidates. This platform focuses on targeting the immune system to treat diseases with high unmet medical needs.
Collaborations
Abivax has established several collaborations with academic institutions and industry partners to advance its research and development programs. These partnerships are aimed at accelerating the development of its product candidates and expanding its technological capabilities.
Corporate Structure
The company is led by a team of experienced executives with backgrounds in biotechnology and pharmaceuticals. Abivax is publicly traded on the Euronext Paris stock exchange.
See also
Related pages
Gallery
-
Abivax Logo
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
